Psoriasis vulgaris


psoriasis: An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None


diagram downward connector

Check conditions None


diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L40.0
Hospital discharge: ICD-9 6961A
Cause of death: ICD-10 L40.0
Cause of death: ICD-9 6961A
KELA reimbursements: KELA codes ANY
KELA reimbursements: ICD-10 L40.0

3 out of 7 registries used, show all original rules.


diagram downward connector

Check minimum number of events None


diagram downward connector

Include endpoints None


diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC


diagram downward connector

Control definitions

Control exclude L12_PAPULOSQUAMOUS

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L40
Name in latin Psoriasis vulgaris

Summary Statistics

Key figures

All Female Male
Number of individuals 5759 2739 3020
Unadjusted prevalence (%) 1.53 1.30 1.82
Mean age at first event (years) 51.05 49.18 52.74


Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.16 [1.52, 3.06] 1.7e-5 542
15 years 0.01 1.65 [1.27, 2.15] 1.9e-4 272
5 years 0.00 2.58 [2.02, 3.29] 2.1e-14 130
1 year 0.00 3.16 [2.14, 4.68] 7.8e-9 30

Age distribution of first events

Year distribution of first events

Cumulative Incidence


Index endpoint: L12_PSORI_VULG – Psoriasis vulgaris
GWS hits: 25

Survival analyses between endpoints


before Psoriasis vulgaris
after Psoriasis vulgaris

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Psoriasis vulgaris

Endpoint not on priority list, no data to show.